Clinical trial

PSMA-PET Guided Radiotherapy

NCT03525288

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2018-05-15

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2018-05-15Date precision: day

Registry last updated2025-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PSMA -PET/CT simulationRADIATION

Standard-care simulationRADIATION

Sponsors & collaborators

Centre hospitalier de l'Université de Montréal (CHUM)lead sponsor

Progenics Pharmaceuticals, Inc.collaborator

Mapped research locations

MontrealQuebec, Canada1 QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03525288 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.